ESMO Congress 2026

Preview news releases and presentations by Dana-Farber Physician-Scientists at this year's ESMO Congress 2026 in Madrid, Spain, October 23 - 27, 2026.
ESMO26: Paolo Tarantino, MD on ADC Resistance in Breast Cancer
Paolo Tarantino, MD, of Dana-Farber Cancer Institute, shows that antibody-drug conjugate (ADC) resistance appears to be driven by complex molecular adaptations beyond target modulation.
Antonio Gioradano, MD, presents efficacy and safety of atirmociclib + fulvestrant in HR+/HER2- advanced breast cancer after progressing on prior CDK4/6 inhibitor - data from phase 2 FOURLIGHT-1 study.
Final analysis of the pivotal KEYNOTE-564 trial in kidney cancer presented by Toni Choueiri, MD. After 7 years of follow-up, adjuvant pembrolizumab continued to extend disease-free survival and overall survival in high-risk clear-cell renal cell carcinoma.
Surprising results in first triplet combination study in advanced kidney cancer presented by Toni Choueiri, MD, at #ESMO26. Dr. Choueiri says even though the combination did not improve efficacy, the findings are important for informing future studies.
Vincent (Wenxin) Xu, MD , shows among patients with advanced kidney cancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors.
News Releases
- Perioperative apalutamide in high-risk localized or locally advanced prostate cancer substudy supports reduced risk of metastasis and death
- Immunotherapy combo extends survival for patients with aggressive small cell lung cancer
- Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium
Featured Speakers
- Presidential Symposium - Jacob Sands, MD
- ESMO/ASCO Evolving Definition of Modern Oncologists - Elizabeth Mittendorf, MD, PhD, MHCM
- Posters and ePoster presentations and abstracts featuring Dana-Farber physician scientists
- Dana-Farber Oral Abstract presentations schedule
Follow us on social media
- X (formerly Twitter)
- @DanaFarber Cancer Institute - Information on our expert cancer care and advanced research
- @DanaFarberNews - Your source for Dana-Farber news
- Bluesky
